blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1221973

EP1221973 - CD40 antagonist for treating psoriasis [Right-click to bookmark this link]
Former [2002/29]CD40 ANTAGONIST FOR TREATING PSORIASIS
[2006/52]
StatusNo opposition filed within time limit
Status updated on  04.04.2008
Database last updated on 03.10.2024
Most recent event   Tooltip07.08.2009Lapse of the patent in a contracting state
New state(s): LU		published on 09.09.2009  [2009/37]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street
Emeryville, CA 94608 / US
[2007/04]
Former [2002/29]For all designated states
CHIRON CORPORATION
4560 Horton Street
Emeryville, California 94608 / US
Inventor(s)01 / CHU, Keting
4560 Horton Street
Emeryville, CA 94608 / US
02 / WANG, Changyu
4560 Horton Street
Emeryville, CA 94608 / US
 [2002/29]
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[N/P]
Former [2002/29]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date00972003.802.10.2000
[2002/29]
WO2000US27184
Priority number, dateUS19990157461P04.10.1999         Original published format: US 157461 P
[2002/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0124823
Date:12.04.2001
Language:EN
[2001/15]
Type: A1 Application with search report 
No.:EP1221973
Date:17.07.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 12.04.2001 takes the place of the publication of the European patent application.
[2002/29]
Type: B1 Patent specification 
No.:EP1221973
Date:30.05.2007
Language:EN
[2007/22]
Search report(s)International search report - published on:EP12.04.2001
ClassificationIPC:A61K39/395, A61P17/06, A61P35/00, C07K16/28
[2007/07]
CPC:
C07K16/2878 (EP,US); A61K39/395 (EP,US); A61P17/00 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P21/00 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P5/14 (EP); A61P5/48 (EP); A61P7/06 (EP);
C07K16/2875 (EP,US); A61K2039/505 (EP,US); C07K2317/24 (EP,US) (-)
C-Set:
A61K39/395, A61K2300/00 (EP,US)
Former IPC [2002/29]A61K39/395, A61P17/06, A61P35/00, // C07K16:28
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/29]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:CD40 Antagonist zur Behandlung von Psoriasis[2006/52]
English:CD40 antagonist for treating psoriasis[2006/52]
French:Antagonistes de CD40 permettant de traiter le psoriasis[2006/52]
Former [2002/29]CD40 ANTAGONIST ZUR BEHANDLUNG VON PSORIASIS
Former [2002/29]CD40 ANTAGONIST FOR TREATING PSORIASIS
Former [2002/29]ANTAGONISTES DE CD40 PERMETTANT DE TRAITER LE PSORIASIS
Entry into regional phase29.04.2002National basic fee paid 
29.04.2002Designation fee(s) paid 
29.04.2002Examination fee paid 
Examination procedure03.05.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.04.2002Examination requested  [2002/29]
13.03.2006Despatch of a communication from the examining division (Time limit: M04)
24.07.2006Reply to a communication from the examining division
17.01.2007Communication of intention to grant the patent
12.04.2007Fee for grant paid
12.04.2007Fee for publishing/printing paid
Divisional application(s)EP07008815.8  / EP1839674
Opposition(s)03.03.2008No opposition filed within time limit [2008/19]
Fees paidRenewal fee
29.04.2002Renewal fee patent year 03
23.10.2003Renewal fee patent year 04
25.10.2004Renewal fee patent year 05
07.10.2005Renewal fee patent year 06
05.10.2006Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT30.05.2007
BE30.05.2007
CY30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
GR31.08.2007
ES10.09.2007
IE02.10.2007
LU02.10.2007
PT30.10.2007
MC31.10.2007
[2009/37]
Former [2009/33]AT30.05.2007
BE30.05.2007
CY30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
GR31.08.2007
ES10.09.2007
IE02.10.2007
PT30.10.2007
MC31.10.2007
Former [2008/48]AT30.05.2007
BE30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
GR31.08.2007
ES10.09.2007
IE02.10.2007
PT30.10.2007
MC31.10.2007
Former [2008/26]AT30.05.2007
BE30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
GR31.08.2007
ES10.09.2007
PT30.10.2007
MC31.10.2007
Former [2008/19]AT30.05.2007
BE30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
GR31.08.2007
ES10.09.2007
PT30.10.2007
Former [2008/10]AT30.05.2007
BE30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
ES10.09.2007
PT30.10.2007
Former [2008/09]AT30.05.2007
BE30.05.2007
DK30.05.2007
FI30.05.2007
NL30.05.2007
SE30.08.2007
ES10.09.2007
Former [2008/08]AT30.05.2007
BE30.05.2007
DK30.05.2007
FI30.05.2007
SE30.08.2007
ES10.09.2007
Former [2008/04]AT30.05.2007
BE30.05.2007
FI30.05.2007
SE30.08.2007
ES10.09.2007
Former [2007/50]AT30.05.2007
FI30.05.2007
SE30.08.2007
ES10.09.2007
Former [2007/48]FI30.05.2007
SE30.08.2007
ES10.09.2007
Former [2007/47]ES10.09.2007
Cited inInternational search[X]WO9803670  (PANGENETICS BV [NL], et al) [X] 1-21,23 * page 6, line 20 - page 7, line 12 * * example 1 * * claim 19 *;
 [X]WO9839026  (BIOGEN INC [US], et al) [X] 1-7,9-15,18-21,23 * page 2, lines 7-15 * * page 5, line 29 - page 8, line 18 * * claims 9,12-16 *;
 [X]WO9912566  (IDEC PHARMA CORP [US]) [X] 1-7,9-15,18-21,23 * page 16, line 20 - page 17, line 25 * * claim - *;
 [PX]US6051228  (ARUFFO ALEJANDRO A [US], et al) [PX] 1-7,9-15,18-21,23 * column 3, lines 47-57 * * column 21, lines 25-31 *;
 [X]  - DENFELD RALF W ET AL, "CD40 is functionally expressed on human keratinocytes.", EUROPEAN JOURNAL OF IMMUNOLOGY, (1996), vol. 26, no. 10, ISSN 0014-2980, pages 2329 - 2334, XP000978801 [X] 1-7,9-15,18-21,23 * abstract * * page 2330, column L, lines 19-23 * * page 2333, column L, paragraph 1 - page 2334, column L, paragraph 1 *

DOI:   http://dx.doi.org/10.1002/eji.1830261009
 [X]  - INGHIRAMI GIORGIO ET AL, "Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma.", BLOOD, (1994), vol. 84, no. 3, ISSN 0006-4971, pages 866 - 872, XP000978806 [X] 22 * page 866, column R, lines 17-21 * * page 870, column L, paragraph 3 *
 [PX]  - MAURI CLAUDIA ET AL, "Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process.", NATURE MEDICINE, (200006), vol. 6, no. 6, ISSN 1078-8956, pages 673 - 679, XP002157458 [PX] 1-5,10-13 * abstract *

DOI:   http://dx.doi.org/10.1038/76251
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.